Can you provide the average price target for EURONEXT NV stock?
20 analysts have analysed ENX.PA and the average price target is 152.64 EUR. This implies a price increase of 5.56% is expected in the next year compared to the current price of 144.6.
EPA:ENX • NL0006294274
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for EURONEXT NV (ENX.PA).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-04-06 | Jefferies | Maintains | Buy -> Buy |
| 2021-08-06 | Credit Suisse | Initiate | |
| 2021-05-24 | UBS | Initiate | Buy |
| 2021-03-03 | Jefferies | Initiate | Buy |
| 2021-02-18 | Deutsche Bank | Initiate | Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.475B 3.94% | 1.627B 10.32% | 1.819B 11.79% | 2.004B 10.18% | 2.115B 5.54% | 2.233B 5.58% | 2.064B -7.57% | 2.128B 3.10% | 2.227B 4.65% | 2.327B 4.49% | |
| EBITDA YoY % growth | 864.666M 6.40% | 1.006B 16.40% | 1.139B 13.14% | 1.243B 9.16% | 1.334B 7.32% | 1.403B 5.17% | 1.337B -4.70% | N/A | N/A | N/A | |
| EBIT YoY % growth | 694.535M 6.45% | 817.712M 17.74% | 938.742M 14.80% | 1.09B 16.11% | 1.181B 8.35% | 1.249B 5.76% | 1.082B -13.37% | N/A | N/A | N/A | |
| Operating Margin | 47.10% | 50.26% | 51.61% | 54.39% | 55.84% | 55.93% | 52.42% | N/A | N/A | N/A | |
| EPS YoY % growth | 5.50 5.97% | 6.57 19.45% | 7.27 10.65% | 7.83 7.71% | 8.57 9.39% | 9.19 7.29% | 9.41 2.40% | N/A | N/A | N/A |
All data in EUR
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.94 7.64% | 2.04 0.95% | 1.90 15.97% | 2.02 11.55% | 2.29 18.04% | 2.38 16.47% | 2.30 20.76% | 2.24 11.16% | 2.38 4.22% | 2.34 -1.34% | 2.46 7.30% | 2.14 -4.59% |
| Revenue Q2Q % growth | 515.43M 12.42% | 509.56M 9.39% | 494.88M 12.96% | 523.97M 12.13% | 558.03M 8.26% | 555.84M 9.08% | 544.82M 10.09% | 557.54M 6.41% | 569.64M 2.08% | 568.63M 2.30% | 553.48M 1.59% | 555.5M -0.37% |
| EBITDA Q2Q % growth | 326.13M 10.85% | 314.98M -46.74% | 311.12M -16.31% | 319.43M -50.20% | 364.27M 11.69% | 357.27M 13.43% | 353.73M 13.70% | 343.14M 7.42% | 369.66M 1.48% | 364.61M 2.05% | 355.52M 0.51% | 324.21M -5.52% |
| EBIT Q2Q % growth | 292.99M 19.15% | 281.03M -43.22% | 275.54M 21.92% | 299.33M -32.20% | 353.39M 20.62% | 346.09M 23.15% | 346.71M 25.83% | 351.41M 17.40% | N/A | N/A | N/A | N/A |
All data in EUR
20 analysts have analysed ENX.PA and the average price target is 152.64 EUR. This implies a price increase of 5.56% is expected in the next year compared to the current price of 144.6.
EURONEXT NV (ENX.PA) will report earnings on 2026-05-19.
The consensus EPS estimate for the next earnings of EURONEXT NV (ENX.PA) is 1.94 EUR and the consensus revenue estimate is 515.43M EUR.
The consensus rating for EURONEXT NV (ENX.PA) is 73 / 100 . This indicates that analysts generally have a positive outlook on the stock.